GET DAILY SIGNALSORCS: Tracking Oracle's (ORCL) Drawdown with the Direxion Daily ORCL Bear 1X ETF
Key Takeaways
- ORCS is the Direxion Daily ORCL Bear 1X ETF, a single-stock fund that seeks -100% (1x inverse) of the daily performance of Oracle (ORCL) common shares.
- Over the trailing 30 days, ORCS has advanced roughly 7%, reflecting a corresponding decline in Oracle's share price.
- The fund trades within a 52-week range of approximately $18.70 to $38.55, with recent trading near the low $31 level.
- Because ORCS rebalances daily and compounds returns, its multi-day performance can diverge meaningfully from a simple -1x Oracle return, making it a short-term tactical tool.
- Oracle's heavy AI capital spending, negative free cash flow, credit downgrade, and changing customer deals are the key inverse drivers behind ORCS.
- For additional detail on this fund's outlook, explore its Price Targets, Earnings, and Forecast pages.
Market Snapshot: Recent Performance of ORCS
ORCS has benefited directly from Oracle's 2026 share-price decline. As the underlying stock sold off through the autumn, the inverse ETF moved from the high $28 range toward the low $31s, delivering a roughly 7% gain over the trailing 30 days. That performance tracks Oracle's slide, which stems from investor questions about financing for its large-scale artificial-intelligence data center investments rather than any drop in reported demand.
Oracle shares were down roughly 40% year-to-date in 2026 and touched a multi-year low in early November. The environment has created positive momentum for ORCS, although the fund remains small with modest assets and lighter trading volume, traits common among single-stock inverse products. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the inverse-ETF space.
Fund Overview: How ORCS Operates
Launched in November 2025, the Direxion Daily ORCL Bear 1X ETF seeks daily investment results, before fees and expenses, equal to -100% of the daily performance of Oracle Corporation's common stock. The fund obtains inverse exposure mainly through swap agreements with major financial institutions and rebalances at the close of each trading day. Its net expense ratio stands at approximately 0.97%.
As a single-stock inverse product, ORCS concentrates exposure in the information technology and software sectors. It suits traders looking to hedge Oracle positions or take a short-term bearish stance without directly shorting the shares. The fund is not designed for buy-and-hold strategies: daily rebalancing and return compounding mean that performance over periods longer than one day can differ from the simple inverse of Oracle's cumulative return, especially in volatile conditions.
Recent Developments Behind ORCS Gains
ORCS moves opposite Oracle, so its recent advance mirrors the company's challenges. In its fiscal first quarter, reported September 10, Oracle delivered 30% year-over-year revenue growth to $19.3 billion and beat earnings expectations, with cloud infrastructure revenue rising sharply. Free cash flow, however, came in negative $5 billion as capital expenditures reached about $28 billion in the quarter, highlighting the financing burden.
That pressure increased in early November when Oracle priced a $20 billion capital raise involving common stock and bonds; the shares fell roughly 9% on the announcement. Around the same time, the company canceled an estimated $7 billion chip-leasing arrangement with Tencent, and a Bloomberg report noted that Microsoft was scaling back its rental of AI computing capacity from Oracle. The stock briefly hit a new 52-week low. Each development supported ORCS inversely. A subsequent rebound in Oracle, partly tied to peer prepayment news, tempered the inverse fund's move.
2026 Outlook: Factors to Monitor
Looking forward, the main driver for ORCS remains Oracle. The company's next quarterly report is expected in mid-December 2026, and attention will focus on whether the contracted backlog holds after recent client-deal adjustments and whether free cash flow begins to turn positive. Capital expenditure guidance, borrowing costs, and any further equity or debt issuance will also receive scrutiny.
Views on Oracle remain split, with some analysts holding optimistic price targets while credit markets and part of the investor community stay cautious about rising debt tied to data center expansion. For ORCS holders, the structural risk lies in the fund's daily reset: prolonged volatility in Oracle can erode value through compounding even if the broader trend is lower. Investors should track Oracle's earnings, financing moves, and AI-sector sentiment before entering inverse positions. From what I see, using Tickeron’s AI Pattern Search Engine offers a quick way to review historical price reactions in similar setups.
Using AI Tools in My Research Process
When analyzing inverse products like ORCS, I often turn to Tickeron’s AI Trading Bots for additional perspective. These automated systems scan thousands of tickers and highlight strategies that align with short-term tactical approaches. The platform curates top-performing bots based on recent results, helping me cross-check momentum signals without replacing my own fundamental review. It is one of several resources I consult when evaluating volatility around single-stock ETFs.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for ORCS turns positive, indicating new upward trend
ORCS saw its Momentum Indicator move above the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator turned positive. In 16 of the 16 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for ORCS just turned positive on November 03, 2026. Looking at past instances where ORCS's MACD turned positive, the stock continued to rise in 8 of 8 cases over the following month. The odds of a continued upward trend are 90%.
ORCS moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +9.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORCS advanced for three days, in 62 of 67 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
ORCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 29 of 32 cases where ORCS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 12 of 12 cases where ORCS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORCS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
Industry description
Advertisement
Advertisement